Effects of otostegia persica (Burm.) boiss on morphine withdrawal syndrome in mice

Iranian Journal of Pharmaceutical Research

Volumn 3, Issue 3, 2004, Pages 171-175

  Hajhashemi, Valiollah ^a   Rabbani, Mohammad ^a   Asghari, Gholam Reza ^a   Karami Saravi, Zaman ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Morphine dependence; Naloxone withdrawal syndrome; Otostegia persica

Indexed keywords

EID: 74549221320     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: 10.22037/ijpr.2010.596     Document Type: Article

References (20)

1. Puri S and Lal H. Effect of dopaminergic stimulation or blockade on morphine withdrawal aggression. Psychopharmacologia (1973) 32: 113-120
2. Lal H and Numan R. Blockade of morphine-withdrawal body shakes by haloperidol. Life Sci. (1976) 18: 163-167
3. Ambrosio E, Igalesias V, Garcia-Lecumberri C, Orensanz L and Algauacil L F. Effect of yohimbine on the development of morphine dependence in the rat: lack of involvement of cortical beta-adrenoceptor modifications. Pharmacol. Biochem. Behav. (1997) 56: 487-491
4. Wange L, Milne B and Jhamandas K. Involvement of excitatory amino acid pathways in the expression of precipitated opioid withdrawal in the rostral ventrolateral medulla: an in vivo voltametric study. Brain Res. (1995) 697: 130-142
5. Tokuyama S, Wakabayashi H and Ho I K. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. (1996) 295: 123-129
6. Gonzalez P, Cabello P, Germany A, Norris B and Contreas E. Decrease of tolerance to, and physical dependence on morphine by glutamate receptor antagonists. Eur. J. Pharmacol. (1997) 332: 257-262
7. Michalska E and Malec D. Agonists and antagonists of adenosine receptors and morphine withdrawal syndrome in rats. Pol. J. Pharmacol. (1993) 45: 1-9
8. Capasso A and Loizzo A. Purinoreceptors are involved in the control of morphine withdrawal. Life Sci. (2001) 69: 179-188
9. Tokuyama S, Zhu H, Oh S, Ho I K and Yamamoto T. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem. Int. (2001) 39: 103-109
10. Herman B H, Vocci F and Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: Medication development issues for opiate addiction. Neuropsychopharmacol. (1995) 13: 269-293
11. El-Kadi A O S and Sharif S I. The role of 5-HT in the expression of morphine withdrawal in mice. Life Sci. (1995) 57: 511-516
12. Bhargava H N. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self administrative behavior. Pharmacol. Rev. (1994) 46: 293-324
13. Akhondzadeh S, Kashani L, Mobasheri M, Hosseini S H and Khani M. Passion flower in the treatment of opiate withdrawal. J. Clin. Pharmacol. Ther. (2001) 26:369-373
14. Hosseinzadeh H and Lary P. Effect of Salvia leriifolia leaf extract on morphine dependent in mice. Phytother. Res. (2000) 14: 384-387
15. Ramezani M, Hosseinzadeh H and Mojtahehdi K. Effects of Ferula gummosa Boiss. Fractions on morphine dependence in mice. J. Ethnopharmacol. (2001) 77: 71-75
16. Sajjadi S E, Movahedian-Atar A M and Yektaian A. Antihyperlipidemic effect of hydroalcoholic extract and polyphenolic fraction from Dracocephalum Kotschyi Boiss. Pharm. Acta Helv. (1998) 73: 167-170
17. Ghasemi N and Moatar F. Laboratory methods in (17) pharmacognosy. Medical University of Isfahan Publication, Isfahan (1996) 11-32
18. Broseta I, Rodriguez-Arias M, Stinus L and Minarro J. Ethological analysis of morphine withdrawal with different dependence programs in male mice. Neuropsychopharmacol. Biol. Psych. (2002) 26: 335-347
19. Capasso A, Piacente S, Pizza C and Sorrention L. Flavonoids reduce morphine withrawal in-vitro. J. Pharm. Pharmacol. (1998) 50: 561-564
20. Hollman P C and Katan M B. Absorption, metabolism and health effects of dietary flavonoids in man . Biomed. Pharmacother. (1997) 51: 305-310